Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Sheridan, E., Wright, J., Small, N., Corry, P. C., Oddie, S., Whibley, C. et al. Risk factors for congenital anomaly in a multiethnic birth cohort: an analysis of the Born in Bradford study. Lancet 382, 1350–1359 (2013).
Deciphering Developmental Disorders Study Prevalence and architecture of de novo mutations in developmental disorders. Nature 542, 433–438 (2017).
Ku, C. S., Polychronakos, C., Tan, E. K., Naidoo, N., Pawitan, Y., Roukos, D. H. et al. A new paradigm emerges from the study of de novo mutations in the context of neurodevelopmental disease. Mol. Psychiatry 18, 141–153 (2013).
Aronson, S. J. & Rehm, H. L. Building the foundation for genomics in precision medicine. Nature 526, 336–342 (2015).
Okur, V., Cho, M. T., Henderson, L., Retterer, K., Schneider, M., Sattler, S. et al. De novo mutations in CSNK2A1 are associated with neurodevelopmental abnormalities and dysmorphic features. Hum. Genet. 135, 699–705 (2016).
Wirkner, U., Voss, H., Ansorge, W. & Pyerin, W. Genomic organization and promoter identification of the human protein kinase CK2 catalytic subunit alpha (CSNK2A1). Genomics 48, 71–78 (1998).
Ceglia, I., Flajolet, M. & Rebholz, H. Predominance of CK2alpha over CK2alpha' in the mammalian brain. Mol. Cell. Biochem. 356, 169–175 (2011).
Niefind, K. & Issinger, O. G. Conformational plasticity of the catalytic subunit of protein kinase CK2 and its consequences for regulation and drug design. Biochim. Biophys. Acta 1804, 484–492 (2010).
Acknowledgements
This research was supported by the Foundation of the University Medical Center Schleswig Holstein ‘Gutes Tun!’ (IH).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies the paper on Journal of Human Genetics website
Supplementary information
Rights and permissions
About this article
Cite this article
Trinh, J., Hüning, I., Budler, N. et al. A novel de novo mutation in CSNK2A1: reinforcing the link to neurodevelopmental abnormalities and dysmorphic features. J Hum Genet 62, 1005–1006 (2017). https://doi.org/10.1038/jhg.2017.73
Published:
Issue date:
DOI: https://doi.org/10.1038/jhg.2017.73
This article is cited by
-
Missense mutation in the activation segment of the kinase CK2 models Okur-Chung neurodevelopmental disorder and alters the hippocampal glutamatergic synapse
Molecular Psychiatry (2025)
-
VEGFR1 as a Target for Cardiovascular Gene Therapy
Journal of Cardiovascular Translational Research (2025)
-
Protein kinase CK2: a potential therapeutic target for diverse human diseases
Signal Transduction and Targeted Therapy (2021)
-
Dual molecular diagnosis of tricho-rhino-phalangeal syndrome type I and Okur-Chung neurodevelopmental syndrome in one Chinese patient: a case report
BMC Medical Genetics (2020)
-
Novel pathogenic variants and multiple molecular diagnoses in neurodevelopmental disorders
Journal of Neurodevelopmental Disorders (2019)